PureTech Health (PRTC) EBIT (2023 - 2025)

PureTech Health (PRTC) has 3 years of EBIT data on file, last reported at -$43.9 million in Q2 2025.

• EBIT for Q2 2025 came in at -$43.9 million, up 20.3% year-over-year; the trailing twelve-month figure through Jun 2025 was -$167.7 million (changed N/A YoY), and the FY2025 annual result was -$98.5 million, up 27.6% from the prior year.
• EBIT improved to -$43.9 million in Q2 2025 per PRTC's latest filing, from -$55.0 million in the prior quarter.
• Over five years, EBIT peaked at -$13.7 million in Q4 2023 and troughed at -$55.0 million in Q2 2024.
• A 3-year average of -$41.9 million and a median of -$49.4 million in 2024 frame the typical range for EBIT.
• The sharpest annual moves came in 2024 and 2025: EBIT tumbled 300.39% in 2024, then increased 20.3% in 2025.
• A 3-year view of EBIT shows it stood at -$13.7 million in 2023, then sank by 300.39% to -$55.0 million in 2024, then grew by 20.3% to -$43.9 million in 2025.
• Business Quant data shows PRTC's EBIT at -$43.9 million in Q2 2025, -$55.0 million in Q4 2024, and -$55.0 million in Q2 2024.